Patients over 60 years old, presence of co-morbidities and current high dose corticosteroid use are associated with a severe course of COVID-19. As diarrhea and abdominal pain may occur in COVID-19 infection, new-onset symptoms must be investigated among IBD patients. Tight control of IBD by continuing diligently on-going medications is essential. Consulting your doctor is also encouraged.